In Brief for Feb. 8, 2023

In Brief for July 26, 2023

IASLC Names New Chief Science Officer

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

Laura Greco of “Die, Cancer, Die!” Fame will be Remembered for her Passionate Patient Advocacy

TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and COVID-19

Lung Cancer Considered - Episode XXV - Mar 16, 2020 Dr. Marty Edelman Speaks With IASLC President Dr. Tetsuya Mitsudomi

Journal Radar: Robust Survival Duration Shown in NSCLC With Pembrolizumab

JAVELIN Lung 200: Potential Reasons for Avelumab’s Failure to Provide OS Benefit

c-MET Antibody–Drug Conjugates: Misconceptions Corrected, Excitement Explained— An Interview with Dr. Karen Kelly

An Interview with Dr. Federico Cappuzzo: Checkpoint Inhibitors Have Replaced Old Strategies

Thoughts on IMpower 150: Latest FDA Approval for Atezolizumab Misses the Mark